TY - JOUR
T1 - Determination of an angiotensin II-regulated proteome in primary human kidney cells by stable isotope labeling of amino acids in cell culture (SILAC)
AU - Konvalinka, Ana
AU - Zhou, Joyce
AU - Dimitromanolakis, Apostolos
AU - Drabovich, Andrei P.
AU - Fang, Fei
AU - Gurley, Susan
AU - Coffman, Thomas
AU - John, Rohan
AU - Zhang, Shao Ling
AU - Diamandis, Eleftherios P.
AU - Scholey, James W.
PY - 2013/8/23
Y1 - 2013/8/23
N2 - Background: Specific markers of kidney angiotensin-II (AngII) activity are needed. Results: Eighteen AngII-regulated proteins were discovered and confirmed by proteomics in human kidney cells, whereas heme oxygenase-1 was validated in a mouse. Conclusion: Heme oxygenase-1 and other AngII-regulated proteins represent novel markers of AngII activity. Significance: AngII-regulated proteins may represent kidney-specific AngII activity markers in patients and in experimental models. Angiotensin II (AngII), the major effector of the renin-angiotensin system, mediates kidney disease progression by signaling through the AT-1 receptor (AT-1R), but there are no specific measures of renal AngII activity. Accordingly, we sought to define an AngII-regulated proteome in primary human proximal tubular cells (PTEC) to identify potential AngII activity markers in the kidney. We utilized stable isotope labeling with amino acids (SILAC) in PTECs to compare proteomes of AngIItreated and control cells. Of the 4618 quantified proteins, 83 were differentially regulated. SILAC ratios for 18 candidates were confirmed by a different mass spectrometry technique called selected reaction monitoring. Both SILAC and selected reaction monitoring revealed heme oxygenase-1 (HO-1) as the most significantly up-regulated protein in response to AngII stimulation. AngII-dependent regulation of the HO-1 gene and protein was further verified in PTECs. To extend these in vitro observations, we overlaid a network of significantly enriched gene ontology terms from our AngII-regulated proteins with a dataset of differentially expressed kidney genes from AngII-treated wild type mice and AT-1R knock-out mice. Five gene ontology terms were enriched in both datasets and included HO-1. Furthermore, HO-1 kidney expression and urinary excretion were reduced in AngIItreated mice with PTEC-specific AT-1R deletion compared with AngII-treated wild-type mice, thus confirming AT-1R-mediated regulation of HO-1. Our in vitro approach identified novel molecular markers of AngII activity, and the animal studies demonstrated that these markers are relevant in vivo. These interesting proteins hold promise as specific markers of renal AngII activity in patients and in experimental models.
AB - Background: Specific markers of kidney angiotensin-II (AngII) activity are needed. Results: Eighteen AngII-regulated proteins were discovered and confirmed by proteomics in human kidney cells, whereas heme oxygenase-1 was validated in a mouse. Conclusion: Heme oxygenase-1 and other AngII-regulated proteins represent novel markers of AngII activity. Significance: AngII-regulated proteins may represent kidney-specific AngII activity markers in patients and in experimental models. Angiotensin II (AngII), the major effector of the renin-angiotensin system, mediates kidney disease progression by signaling through the AT-1 receptor (AT-1R), but there are no specific measures of renal AngII activity. Accordingly, we sought to define an AngII-regulated proteome in primary human proximal tubular cells (PTEC) to identify potential AngII activity markers in the kidney. We utilized stable isotope labeling with amino acids (SILAC) in PTECs to compare proteomes of AngIItreated and control cells. Of the 4618 quantified proteins, 83 were differentially regulated. SILAC ratios for 18 candidates were confirmed by a different mass spectrometry technique called selected reaction monitoring. Both SILAC and selected reaction monitoring revealed heme oxygenase-1 (HO-1) as the most significantly up-regulated protein in response to AngII stimulation. AngII-dependent regulation of the HO-1 gene and protein was further verified in PTECs. To extend these in vitro observations, we overlaid a network of significantly enriched gene ontology terms from our AngII-regulated proteins with a dataset of differentially expressed kidney genes from AngII-treated wild type mice and AT-1R knock-out mice. Five gene ontology terms were enriched in both datasets and included HO-1. Furthermore, HO-1 kidney expression and urinary excretion were reduced in AngIItreated mice with PTEC-specific AT-1R deletion compared with AngII-treated wild-type mice, thus confirming AT-1R-mediated regulation of HO-1. Our in vitro approach identified novel molecular markers of AngII activity, and the animal studies demonstrated that these markers are relevant in vivo. These interesting proteins hold promise as specific markers of renal AngII activity in patients and in experimental models.
UR - http://www.scopus.com/inward/record.url?scp=84883180458&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84883180458&partnerID=8YFLogxK
U2 - 10.1074/jbc.M113.485326
DO - 10.1074/jbc.M113.485326
M3 - Article
C2 - 23846697
AN - SCOPUS:84883180458
SN - 0021-9258
VL - 288
SP - 24834
EP - 24847
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 34
ER -